Reports for RIVASTIGMINE
Ingredient
RIVASTIGMINE
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Actual shortage | 2025-02-13 | 2025-02-13 | 250310 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Actual shortage | 2024-11-29 | 2025-02-06 | 244209 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2024-05-03 | 2024-05-17 | 227085 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2023-09-28 | 2024-01-05 | 205501 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2021-07-05 | 2021-12-03 | 141854 |
| APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2019-06-12 | 2019-10-07 | 86336 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2022-11-27 | 2023-03-09 | 175898 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2024-03-08 | 2024-05-10 | 221729 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2023-07-21 | 2024-01-05 | 199518 |
| APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2017-03-11 | 2017-05-18 | 487 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254234 |
| RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254237 |
| RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2025-04-04 | 2025-04-05 | 254240 |
| RIVASTIGMINE | 6MG | CAPSULE | To be discontinued | 2025-04-04 | 2025-04-04 | 254243 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245285 |
| SANDOZ RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2024-12-10 | 2024-12-11 | 245288 |